Kiromic Biopharma Stock Three Year Return
Kiromic Biopharma fundamentals help investors to digest information that contributes to Kiromic Biopharma's financial success or failures. It also enables traders to predict the movement of Kiromic Stock. The fundamental analysis module provides a way to measure Kiromic Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kiromic Biopharma stock.
Kiromic |
Kiromic Biopharma Company Three Year Return Analysis
Kiromic Biopharma's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
CompetitionBased on the latest financial disclosure, Kiromic Biopharma has a Three Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Kiromic Fundamentals
Return On Equity | -11.3 | ||||
Return On Asset | -0.92 | ||||
Current Valuation | 9.55 M | ||||
Shares Outstanding | 1.18 M | ||||
Shares Owned By Insiders | 3.91 % | ||||
Shares Owned By Institutions | 68.00 % | ||||
Number Of Shares Shorted | 45.74 K | ||||
Price To Book | 15.11 X | ||||
EBITDA | (29.44 M) | ||||
Net Income | (34.73 M) | ||||
Cash And Equivalents | 6.51 M | ||||
Cash Per Share | 0.41 X | ||||
Total Debt | 9.41 M | ||||
Debt To Equity | 0.20 % | ||||
Current Ratio | 1.35 X | ||||
Book Value Per Share | (5.35) X | ||||
Cash Flow From Operations | (23.75 M) | ||||
Short Ratio | 0.93 X | ||||
Earnings Per Share | (39.68) X | ||||
Number Of Employees | 31 | ||||
Beta | 0.16 | ||||
Market Capitalization | 2.15 M | ||||
Total Asset | 11.97 M | ||||
Retained Earnings | (101.95 M) | ||||
Working Capital | (11.59 M) | ||||
Z Score | -21.07 | ||||
Net Asset | 11.97 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |